Clinical Trial: Cancer

Wilms' tumor study (low & standard risk)

Full Name
Temporarily Closed to Enrollment/ Kidney Tumor in Children (COG #AREN0532): Treatment for very low and standard risk favorable histology Wilms' tumor (1_PRO00000567 - CIRB)

Description

All participants on this study must have been enrolled on AREN03B2. There are three arms to this study. Participants will receive nephrectomy and observation only; or chemotherapy alone; or chemotherapy with radiation therapy. Most participants will have had total resection of the kidney and tumor. Patients with unresectable or incompletely resected tumors will receive chemotherapy and be re-evaluated following 2 cycles (approximately 6 weeks). If the tumor is determined to be resectable, further surgery will be performed.

Eligibility

Inclusion Criteria
  • Less than 30 years of age
  • Diagnosed with a Stage 1-III diagnosis of Wilms' Tumor
  • Must have an appropriate performance level
  • No prior directed Chemotherapy or Radiation Therapy
  • Must have adequate organ function
  • Cannot become pregnant or breastfeed
  • Sexually active patients must agree to use adequate birth control